白细胞介素-18通过诱导Fas配体表达治疗增生性瘢痕
该研究探讨IL-18通过增强FasL表达对增生性瘢痕的作用。方法包括检测瘢痕与正常组织中IL-18表达、rhIL-18处理增生性瘢痕成纤维细胞及兔耳瘢痕模型注射。结果显示IL-18在瘢痕中降低,rhIL-18抑制成纤维细胞增殖并促进凋亡,且改善兔耳瘢痕VAS和厚度。结论:IL-18是潜在治疗靶点。
要点
- 增生性瘢痕组织和成纤维细胞中IL-18表达降低。
- rhIL-18剂量依赖性抑制瘢痕成纤维细胞增殖并促进凋亡,伴FasL等表达增强。
- 兔耳瘢痕注射rhIL-18后VAS、瘢痕厚度和SEI降低,FasL表达增加。
核心结论
- IL-18通过增强FasL表达抑制增生性瘢痕成纤维细胞增殖并促进凋亡,是潜在治疗靶点。
研究设计与样本
- 研究纳入增生性瘢痕组织和正常组织,比较IL-18表达。
- 体外用rhIL-18处理增生性瘢痕成纤维细胞,检测增殖、凋亡及FasL等相关分子。
- 体内在兔耳增生性瘢痕模型注射rhIL-18,观察组织学变化和VAS评分。
主要发现
- 增生性瘢痕组织和成纤维细胞中IL-18表达较正常组织和细胞降低。
- rhIL-18处理使增生性瘢痕成纤维细胞增殖下降、凋亡增加,并剂量依赖性增强FasL、sFasL、FADD、Caspase-8、Caspase-9和Caspase-3表达。
- 兔耳瘢痕注射rhIL-18后随时间推移VAS和瘢痕厚度降低,SEI下降且FasL表达增加。
临床怎么用
- IL-18可能作为增生性瘢痕的潜在治疗靶点,通过调控FasL诱导成纤维细胞凋亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Among downstream interleukin-18 (IL-18) targets, Fas ligand (FasL) in particular, has been strongly implicated in many conditions. Our study aims to explore the role of IL-18 in hypertrophic scar through enhancing FasL expression. METHODS: IL-18 expression in hypertrophic scar tissues and normal tissues were explored by immunohistochemistry, qRT-PCR and Western blotting, and the expression of IL-18 in normal skin fibroblasts and hypertrophic scar fibroblasts by immunofluorescence. Hypertrophic scar fibroblasts treated with recombinant human IL-18 (rhIL-18) were assessed with MTT, Annexin V-FITC/PI, qRT-PCR, ELISA and western blotting. In the hypertrophic scar of rabbit ears, rhIL-18 was injected to determine histological changes with HE and Masson staining. Additionally, the scars were rated based on contour and overall severity using a visual analog scale scores (VAS). RESULTS: IL-18 was decreased in hypertrophic scar tissues and fibroblasts compared to normal skin tissues and fibroblasts, respectively. Decreased proliferation and increased apoptosis of hypertrophic scar fibroblasts were found after rhIL-18 treatment with enhanced expression of FasL, sFasL FADD, Caspase-8, Caspase-9 and Caspase-3 in a dose-dependent manner. The VAS and thickness of scars in rabbit ears was decreased as time went on after rhIL-18 treatment, with decreases in scar elevation index (SEI) and the increases in FasL expression. CONCLUSION: IL-18 curbs proliferation and promotes apoptosis of hypertrophic scar fibroblasts by enhancing FasL expression. IL-18is a potential target for treatment of hypertrophic scar.
引用
- Le X, Wu WW. The therapeutic effect of Interleukin-18 on hypertrophic scar through inducing Fas ligand expression. Burns. 2020. PMID: 32782165. doi:10.1016/j.burns.2020.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。